TABLE 3.
Sample |
Driver mutation |
Secondary mutation |
|||||
---|---|---|---|---|---|---|---|
Day | RSCV no. | Wound no. | Gene | Mutationa | Frequency (%) | Gene | Mutation |
3 | 1 | 1 | wspA | 285-298del | pslO-pslE | Δ14,299 bp | |
2 | 2 | wspA | 285-298del | ||||
pslO-pslE | Δ14,299 bp | ||||||
4 | 1 | wspA | 285-298del | PA14_13130/PA14_13140 | TNN→TGC | ||
fabI/ppiD | TTC→TCC | ||||||
Day 3 summary | wspA | 285-298del | 100 | ||||
14 | 3 | 4 | wspA | 285-298del | |||
6 | 4 | wspA | 285-298del | ||||
7 | 4 | wspA | 285-298del | ||||
8 | 4 | wspA | 285-298del | ||||
9 | 4 | wspA | 285-298del | ||||
10 | 4 | wspA | 285-298del | ||||
12 | 4 | wspA | 285-298del | CRISPR–Cas1/hpb | +60bp | ||
13 | 1 | wspA | 285-298del | Glutamyl-tRNA reductase | L71L (CTG→TTG) | ||
14 | 4 | wspA | 285-298del | fabI/ppiD | TTC→TCC | ||
16 | 4 | wspA | 285-298del | ||||
17 | 4 | wspA | 285-298del | ||||
20 | 4 | wspF | V154fs | ||||
24 | 1 | wspA | 285-298del | ||||
27 | 1 | wspA | 285-298del | ||||
28 | 2 | wspA | 285-298del | ||||
36 | 3 | wspF | V154fs | ||||
37 | 3 | wspA | 285-298del | ||||
38 | 3 | wspF | V154fs | ||||
86 | 3 | wspA | 285-298del | CRISPR–Cas1/hp | +60bp | ||
Day 14 summary | wspA | 285-298del | 84.2 | ||||
wspF | V154fs | 15.8 | |||||
28 | G→TT 585bp | ||||||
wspD | CT→AG 588-589bp | ||||||
40 | 1 | wspA | 285-298del | S197S (TCG→TCA) | |||
PA14_54090 | A248V (GCG→GTG) | ||||||
42 | 3 | wspA | 285-298del | ||||
43 | 3 | wspA | 285-298del | ||||
45 | 3 | wspA | 285-298del | ||||
87 | 2 | wspA | 285-298del | ||||
Day 28 summary | wspA | 285-298del | 100 |
Deleted amino acid residues are indicated. del, deletion; fs, frameshift.
hp, hypothetical protein.